Biological Products, (no Disgnostic Substances) Industry Tickers

Showing 160 tickers (Page 1 of 2)

	Ticker	Company Name	Exchange	Type	Market Cap
-	FDMT	4D Molecular Therapeutics, Inc. Common Stock	XNAS	CS	$490.38M
-	ABP	Abpro Holdings, Inc Common Stock	XNAS	CS	$15.02M
-	ABOS	Acumen Pharmaceuticals, Inc. Common Stock	XNAS	CS	$113.88M
-	ADPT	Adaptive Biotechnologies Corporation Common Stock	XNAS	CS	$2.26B
-	ADMA	ADMA Biologics, Inc.	XNAS	CS	$3.46B
-	ADVM	Adverum Biotechnologies, Inc. Common Stock	XNAS	CS	$95.03M
-	AGEN	Agenus Inc.	XNAS	CS	$126.82M
-	AIM	AIM ImmunoTech Inc.	XASE	CS	$4.64M
-	ALEC	Alector, Inc. Common Stock	XNAS	CS	$139.71M
-	ALGS	Aligos Therapeutics, Inc. Common Stock	XNAS	CS	$49.15M
-	ALLO	Allogene Therapeutics, Inc. Common Stock	XNAS	CS	$261.82M
-	ACOG	Alpha Cognition Inc. Common Stock	XNAS	CS	$119.56M
-	AMGN	Amgen Inc	XNAS	CS	$172.42B
-	AVXL	Anavex Life Sciences	XNAS	CS	$626.17M
-	APGE	Apogee Therapeutics, Inc. Common Stock	XNAS	CS	$3.70B
-	ACLX	Arcellx, Inc. Common Stock	XNAS	CS	$5.00B
-	ARMP	Armata Pharmaceuticals, Inc. Common Stock	XASE	CS	$209.41M
-	ARTV	Artiva Biotherapeutics, Inc. Common Stock	XNAS	CS	$84.51M
-	ATRA	Atara Biotherapeutics, Inc	XNAS	CS	$82.94M
-	ATHA	Athira Pharma, Inc. Common Stock	XNAS	CS	$15.18M
-	ATYR	aTyr Pharma, Inc. Common Stock	XNAS	CS	$80.05M
-	AURA	Aura Biosciences, Inc. Common Stock	XNAS	CS	$332.34M
-	AUTL	Autolus Therapeutics plc American Depositary Share	XNAS	ADRC	$353.97M
-	BEAM	Beam Therapeutics Inc. Common Stock	XNAS	CS	$2.25B
-	TECH	Bio-Techne Corp.	XNAS	CS	$8.95B
-	BCAB	BioAtla, Inc. Common Stock	XNAS	CS	$40.32M
-	BCDA	BioCardia, Inc. Common Stock	XNAS	CS	$13.80M
-	BCRX	BioCryst Pharmaceuticals Inc	XNAS	CS	$1.49B
-	BIIB	Biogen Inc. Common Stock	XNAS	CS	$22.81B
-	PHGE	BiomX Inc.	XASE	CS	$10.70M
-	BDTX	Black Diamond Therapeutics, Inc. Common Stock	XNAS	CS	$221.48M
-	BKHA	Black Hawk Acquisition Corporation Class A Ordinary Shares	XNAS	CS	$46.52M
-	BKHAR	Black Hawk Acquisition Corporation Rights	XNAS	RIGHT	-
-	BKHAU	Black Hawk Acquisition Corporation Units	XNAS	UNIT	-
-	CCCC	C4 Therapeutics, Inc.	XNAS	CS	$226.78M
-	CABA	Cabaletta Bio, Inc. Common Stock	XNAS	CS	$233.24M
-	CLDI	Calidi Biotherapeutics, Inc.	XASE	CS	$7.65M
-	CADL	Candel Therapeutics, Inc. Common Stock	XNAS	CS	$276.67M
-	CRDF	Cardiff Oncology, Inc. Common Stock	XNAS	CS	$147.52M
-	CRBU	Caribou Biosciences, Inc. Common Stock	XNAS	CS	$194.63M
-	CVM	Cel-Sci Corporation	XASE	CS	$56.27M
-	IPSC	Century Therapeutics, Inc. Common Stock	XNAS	CS	$46.20M
-	CGON	CG Oncology, Inc. Common stock	XNAS	CS	$3.03B
-	CSBR	Champions Oncology, Inc.	XNAS	CS	$92.93M
-	CDTX	Cidara Therapeutics, Inc.	XNAS	CS	$3.28B
-	CGTX	Cognition Therapeutics, Inc. Common Stock	XNAS	CS	$146.45M
-	CHRS	Coherus Oncology, Inc. Common Stock	XNAS	CS	$155.74M
-	CMPX	Compass Therapeutics, Inc. Common Stock	XNAS	CS	$752.36M
-	CELZ	Creative Medical Technology Holdings, Inc. Common Stock	XNAS	CS	$7.79M
-	CRSP	CRISPR Therapeutics AG	XNAS	CS	$5.01B
-	CGEM	Cullinan Therapeutics, Inc. Common Stock	XNAS	CS	$424.76M
-	CRIS	Curis Inc	XNAS	CS	$16.37M
-	DBVT	DBV Technologies S.A.	XNAS	CS	$502.20M
-	DNLI	Denali Therapeutics Inc. Common Stock	XNAS	CS	$2.20B
-	DYAI	Dyadic International, Inc.	XNAS	CS	$33.82M
-	EDIT	Editas Medicine, Inc. Common Stock	XNAS	CS	$222.10M
-	ELUT	Elutia Inc. Class A Common Stock	XNAS	CS	$37.95M
-	ENGN	enGene Holdings Inc. Common Stock	XNAS	CS	$310.22M
-	ENGNW	enGene Holdings Inc. Warrants	XNAS	WARRANT	-
-	ENTX	Entera Bio Ltd. Ordinary Shares	XNAS	CS	$143.38M
-	ESLA	Estrella Immunopharma, Inc. Common Stock	XNAS	CS	$108.60M
-	ESLAW	Estrella Immunopharma, Inc. Warrant	XNAS	WARRANT	-
-	EXEL	Exelixis Inc	XNAS	CS	$10.94B
-	EXOZ	eXoZymes Inc. Common Stock	XNAS	CS	$117.42M
-	FATE	Fate Therapeutics, Inc.	XNAS	CS	$123.40M
-	FENC	Fennec Pharmaceuticals Inc. Common Stock	XNAS	CS	$222.10M
-	GILD	Gilead Sciences Inc	XNAS	CS	$147.60B
-	DNA	Ginkgo Bioworks Holdings, Inc.	XNYS	CS	$529.84M
-	HALO	Halozyme Therapeutics, Inc.	XNAS	CS	$8.02B
-	HUMA	Humacyte, Inc. Common Stock	XNAS	CS	$249.07M
-	HUMAW	Humacyte, Inc. Warrant	XNAS	WARRANT	-
-	IMA	ImageneBio, Inc. Common Stock	XNAS	CS	$92.70M
-	IBRX	ImmunityBio, Inc. Common Stock	XNAS	CS	$2.10B
-	IMCR	Immunocore Holdings plc American Depositary Shares	XNAS	ADRC	$1.69B
-	IMVT	Immunovant, Inc. Common Stock	XNAS	CS	$4.07B
-	INAB	IN8bio, Inc. Common Stock	XNAS	CS	$7.04M
-	IKT	Inhibikase Therapeutics, Inc. Common Stock	XNAS	CS	$111.77M
-	INBX	Inhibrx Biosciences, Inc. Common Stock	XNAS	CS	$1.17B
-	INMB	INmune Bio Inc. Common stock	XNAS	CS	$43.33M
-	TIL	Instil Bio, Inc. Common Stock	XNAS	CS	$101.87M
-	INTS	Intensity Therapeutics, Inc. Common stock	XNAS	CS	$27.31M
-	IVVD	Invivyd, Inc. Common Stock	XNAS	CS	$339.84M
-	IOVA	Iovance Biotherapeutics, Inc. Common Stock	XNAS	CS	$913.03M
-	JSPRW	Japer Therapeutics, Inc. Warrants	XNAS	WARRANT	-
-	JSPR	Jasper Therapeutics, Inc. Common Stock	XNAS	CS	$49.70M
-	KLRS	Kalaris Therapeutics, Inc. Common Stock	XNAS	CS	$88.84M
-	KLTO	Klotho Neurosciences, Inc. Common Stock	XNAS	CS	$28.72M
-	KLTOW	Klotho Neurosciences, Inc. Warrant	XNAS	WARRANT	-
-	KOD	Kodiak Sciences Inc Common Stock	XNAS	CS	$931.25M
-	KRYS	Krystal Biotech, Inc. Common Stock	XNAS	CS	$5.73B
-	KYMR	Kymera Therapeutics, Inc. Common Stock	XNAS	CS	$4.22B
-	KYTX	Kyverna Therapeutics, Inc. Common Stock	XNAS	CS	$284.56M
-	LENZ	LENZ Therapeutics, Inc. Common Stock	XNAS	CS	$718.73M
-	LXEO	Lexeo Therapeutics, Inc. Common Stock	XNAS	CS	$597.77M
-	LIMN	Liminatus Pharma, Inc. Class A Common Stock	XNAS	CS	$31.53M
-	LIMNW	Liminatus Pharma, Inc. Warrants	XNAS	WARRANT	-
-	LCTX	Lineage Cell Therapeutics, Inc.	XASE	CS	$405.38M
-	MAZE	Maze Therapeutics, Inc. Common Stock	XNAS	CS	$1.38B
-	MGTX	MeiraGTx Holdings plc Ordinary Shares	XNAS	CS	$681.39M
-	MGX	Metagenomi, Inc. Common Stock	XNAS	CS	$81.07M